Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-17-002100
Accepted
2017-08-14 00:15:19
Documents
1
Effectiveness Date
2017-08-11
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 592
  Complete submission text file 9999999995-17-002100.txt   1783
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: EFFECT | Act: 33 | File No.: 333-219385 | Film No.: 171026655
SIC: 2834 Pharmaceutical Preparations